다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of molecular and cellular cardiology, v.32 no.12, 2000년, pp.2339 - 2347
Xu, Zhelong (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA) , Yang, Xi-Ming (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA) , Cohen, Michael V (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA) , Neumann, Till (Department of Pathophysiology, University of Essen, Essen, Germany) , Heusch, Gerd (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA) , Downey, James M (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA)
AI-Helper
AbstractThe novel A1/A2adenosine receptor agonist AMP 579 has been reported to reduce myocardial infarct size in pig and dog. The present study tested the effect of AMP 579 in two rabbit models. In open-chest rabbits undergoing 30 min of regional ischemia and 3 h of reperfusion AMP 579 (3 μ g...
Circulation Toombs 86 986 1992 10.1161/01.CIR.86.3.986 Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia
Circulation Thornton 85 659 1992 10.1161/01.CIR.85.2.659 Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction
Circulation Olafsson 76 1135 1987 10.1161/01.CIR.76.5.1135 Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon
Circulation Pitarys 83 237 1991 10.1161/01.CIR.83.1.237 Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period
Coron Artery Dis Zhao 10 617 1999 10.1097/00019501-199912000-00011 Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes
Cardiovasc Res Goto 25 943 1991 10.1093/cvr/25.11.943 Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species
Cardiovasc Res Vander Heide 31 711 1996 10.1016/S0008-6363(95)00235-9 Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs
J Pharmacol Exp Ther Smits 286 611 1998 Cardioprotective effects of the novel adenosine A1/A2receptor agonist AMP 579 in a porcine model of myocardial infarction
J Cardiovasc Pharmacol McVey 33 703 1999 10.1097/00005344-199905000-00005 Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium
Am J Physiol Jordan 277 H1895 1999 A3adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury
J Mol Cell Cardiol Shirato 21 1187 1989 10.1016/0022-2828(89)90695-0 Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart
Basic Res Cardiol Miki 94 180 1999 10.1007/s003950050141 Failure of N-2-mercaptopropionyl glycine to reduce myocardial infarction after 3 days of reperfusion in rabbits
Washington: National Academy Press National Research Council 1996 Guide for the care and use of laboratory animals
Circulation Weinbrenner 98 899 1998 10.1161/01.CIR.98.9.899 Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia
Cardiovasc Res Weinbrenner 38 676 1998 10.1016/S0008-6363(98)00064-9 Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia
Am J Physiol Zhao 273 H1677 1997 Adenosine inhibition of neutrophil damage during reperfusion does not involve KATP-channel activation
Am Heart J Norton 123 332 1992 10.1016/0002-8703(92)90643-A The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury
Cardiovasc Res Budde 47 294 2000 10.1016/S0008-6363(00)00115-2 Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion
Circulation Baxter 102 (Suppl. II) II 2000 Amp579, an A1/A2A agonist, limits infarct size at reperfusion via a P42/P44 MAPK-dependent pathway (Abstract)
Circulation Murry 74 1124 1986 10.1161/01.CIR.74.5.1124 Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium
Circulation Liu 84 350 1991 10.1161/01.CIR.84.1.350 Protection against infarction afforded by preconditioning is mediated by A1adenosine receptors in rabbit heart
Cardiovasc Res Tsuchida 26 456 1992 10.1093/cvr/26.5.456 Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning
J Mol Cell Cardiol Grover 32 677 2000 10.1006/jmcc.2000.1111 ATP-sensitive potassium channels: a review of their cardioprotective pharmacology
J Mol Cell Cardiol Zhao 24 (Suppl. III) S.8 1992 Receptor-mediated reduction of myocardial infarct size and attenuated no-reflow by endogIenous adenosine during ischemia and reperfusion (Abstract)
J Cardiovasc Electrophysiol Baines 10 741 1999 10.1111/j.1540-8167.1999.tb00251.x Signal transduction in ischemic preconditioning: the role of kiInases and mitochondrial KATPchannels
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.